All In MedTech

Device type · CAC

Apparatus, Autotransfusion

FDA groups similar devices under a three-letter product code. This page gathers what FDA's public data says about CAC: how it is classified, what has been cleared or approved, and what has been reported and recalled.

Last checked: Nov 19, 2026Source: openFDAMethods & limitations

Product code

CAC

Cardiovascular

Device class

Class II

FDA decisions since 2015

17

510(k), De Novo and PMA

Adverse event reports

106

Received Nov 1, 2025 to Nov 19, 2026

How FDA classifies it

Device type
Apparatus, Autotransfusion
Product code
CAC
Device class
Class II
Review panel
Cardiovascular
Regulation
21 CFR 868.5830
Specialty
Cardiology

Latest FDA decisions

The 8 newest of 17 since 2015.

All decisions for CAC

14 more FDA decisions with a free account

Reports received

106

Received Nov 1, 2025 to Nov 19, 2026

Malfunction reports

91

86% of reports

Injury reports

13

12% of reports

Death reports

2

1.9% of reports

Adverse event reports received per month

By the date FDA received each report, stacked by event type. The newest month is incomplete.

Open in the MAUDE Monitor
  • Malfunction
  • Injury
  • Death
  • Other
View as table
MonthMalfunctionInjuryDeathOther
Dec 231100
Jan 242000
Feb 244110
Mar 242100
Apr 246100
May 246300
Jun 246100
Jul 2410100
Aug 247400
Sep 2415100
Oct 2413100
Nov 2436400
Dec 242100
Jan 2517000
Feb 2510000
Mar 2513000
Apr 258110
May 258100
Jun 257000
Jul 259000
Aug 2517400
Sep 2511000
Oct 258000
Nov 253200
Dec 258000
Jan 2610000
Feb 265220
Mar 267300
Apr 267100
May 2610000
Jun 2610100
Jul 268100
Aug 267100
Sep 267000
Oct 269200
Nov 260000

Manufacturers named most often

Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.

2 more in this ranking with a free account

Device problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • Fluid/Blood Leak42
  • Mechanical Problem21
  • Optical Problem19

7 more in this ranking with a free account

Patient problems as coded

Last 12 months. FDA's terms. A report can carry several.

  • No Clinical Signs, Symptoms or Conditions65
  • Hemorrhage/Blood Loss/Bleeding47
  • Perforation of Vessels3

5 more in this ranking with a free account

Recent recalls

From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

  • Maquet Cardiovascular, LLC

    Z-0709-2024 · Started Dec 13, 2023 · Posted by FDA Jan 12, 2024

    Reason given: Express chest drains are pre-packaged with sterile water syringes which have bene recalled. If the device is not kept in an upright position, the patient may be exposed to infectious material. Subsequent hazards include but are not limited to infection, abscess, sepsis, and death.

    Cause as FDA categorized it: Material/Component Contamination

  • Maquet Cardiovascular, LLC

    Z-0710-2024 · Started Dec 13, 2023 · Posted by FDA Jan 12, 2024

    Reason given: Express chest drains are pre-packaged with sterile water syringes which have bene recalled. If the device is not kept in an upright position, the patient may be exposed to infectious material. Subsequent hazards include but are not limited to infection, abscess, sepsis, and death.

    Cause as FDA categorized it: Material/Component Contamination

  • Atrium Medical Corporation

    Z-0621-2024 · Started Nov 1, 2023 · Posted by FDA Dec 28, 2023

    Reason given: A sterilization nonconformance prematurely aged the product by 48.3 days, resulting in the expiration date on the label not being accurate. This nonconforming product was inadvertently distributed to customers. Increased risk to patients and healthcare providers using the product after the shortened expiration date of...

    Cause as FDA categorized it: Nonconforming Material/Component

86 more recall records with a free account

Back to all tools

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.